Experimental duel angiogenic inhibitor outperforms ranibizumab for DME

This phase 2 study reports the safety and efficacy of faricimab for diabetic macular edema (DME).
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553